Position in BMY
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$11,991,413
+$11,508,700 QoQ
Shares Held
208,112
+2514.8% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
1.63%
of 13F equity value
Holder Rank
#369
of 2,506 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Mayflower Financial Advisors, LLC holds $56,704,468 across 12 Drug Manufacturers - General names. BMY ranks #2 (21.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
101,672 | $25,584,742 | |
| 2 | BMY |
Bristol Myers Squibb Co
This page
|
208,112 | $11,991,413 | |
| 3 | JNJ |
Johnson & Johnson
|
24,544 | $6,233,439 | |
| 4 | LLY |
ELI LILLY & Co
|
3,906 | $4,684,973 | |
| 5 | MRK |
Merck & Co., Inc.
|
20,163 | $2,590,945 | |
| 6 | PFE |
Pfizer Inc
|
58,088 | $1,398,759 | |
| 7 | NVS |
Novartis AG
|
8,591 | $1,346,381 | |
| 8 | AMGN |
Amgen Inc
|
3,665 | $1,327,169 |
All Filings in BMY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,991,413 | 208,112 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $482,713 | 7,959 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $415,391 | 7,701 | Shares | Sole | 2026-01-13 | |
| 2025-09-30 | $355,839 | 7,890 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $390,595 | 8,438 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $971,814 | 15,934 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $660,733 | 11,682 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $438,030 | 8,466 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $343,619 | 8,274 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $511,009 | 9,423 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $10,948,681 | 213,383 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $12,470,474 | 214,860 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $13,743,366 | 214,908 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $14,910,660 | 215,130 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $15,567,677 | 216,368 | Shares | Sole | 2023-01-25 | |
| 2022-09-30 | $16,079,633 | 226,187 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $17,403,694 | 226,022 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $16,513,616 | 226,121 | Shares | Sole | 2022-04-21 | |
| 2021-12-31 | $14,053,378 | 225,395 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $13,348,633 | 225,598 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $15,071,251 | 225,550 | Shares | Sole | 2021-07-29 | |
| 2021-03-31 | $13,500,981 | 213,860 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $13,246,196 | 213,545 | Shares | Sole | 2021-04-12 | |
| No filing history on record for this holder in this stock. | ||||||